Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Emerald Health Therapeutics Inc
EMHTF
Healthcare
Drug Manufacturers - Specialty & Generic
Cannabis
Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
OTCQB:EMHTF - Post Discussion
Emerald Health Therapeutics Inc
> we are separating the wheat from the chaff - EMH - EMHTF
New Post
View:
Discussion
List
(30)
•••
FelixFun
X
View Profile
View Bullboard History
Post by
FelixFun
on Nov 09, 2018 6:22am
we are separating the wheat from the chaff - EMH - EMHTF
I think that many retail investors were insecure and took their money off the market because of the fall in prices after 17 October. The rest of the private investors are now trying to benefit from swing trades and are jumping from one company to the next. However, confidence has now returned and both groups are now considering where to invest their money in the longer term. For a
majority
Emerald now seems to be presenting itself all the more clearly as a winning company and distinguishing itself from other companies of its size with a
well thought-out
business model. The
Pure Sunfarms
company-project, with production costs below 1 $ per gram, the cooperation with
Factors
, the inclusion of the natural remedies market in cooperation with Emerald Bioceuticals via
Emerald Naturals
to build a promotional bridge to the new cannabis products, the cooperation with research laboratories (
Vivacell
) that can develop and with laboratories (
Northern Vine
) that could test and even distribute new products etc. etc. etc.
All these things are important because they are facts that justifies investments.
The big hype is over! Now the process begins where everyone carefully separates the wheat from the chaff. The big investors are just around the corner. One of their favorites will be Emerald Health Therapeutics. I am very convinced of that!
All those who still doubt should read this PDF carefully ...
EMERALD HEALTH THERAPEUTICS - INVESTOR PRESENTATION - Oct 25, 2018
(62)
•••
junkyardawg
X
View Profile
View Bullboard History
Comment by
junkyardawg
on Nov 09, 2018 10:13am
Excellent post FelixF! The PDF paints a comprehensive picture of EMH and illustrates a lot of the reasons they should be near the front of the pack. Thank you. JYD
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario